DKM Wealth Management’s AbCellera Biologics ABCL Stock Holding History

DKM Wealth Management’s Portfolio ABCL Stock Details ABCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$146K	Hold	10,000	–	–	0.09%	62
2026 Q2	$78.5K	Hold	10,000	–	–	0.05%	65
2026 Q1	$34.9K	Hold	10,000	–	–	0.03%	67
2025 Q4	$34.2K	Hold	10,000	–	–	0.03%	69
2025 Q3	$50.3K	Hold	10,000	–	–	0.04%	62
2025 Q2	$34.3K	Hold	10,000	–	–	0.03%	56
2025 Q1	$22.3K	Hold	10,000	–	–	0.02%	50
2024 Q4	$29.3K	Buy	+10,000	New	+$27.8K	0.03%	52

Other funds holding ABCL

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

GAA

Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Pacifica Partners Surrey, Canada $332M AUM 43.09% 1-Year Est. Return

CIA

Cape Investment Advisory Mcdonough, Georgia $388M AUM 17.15% 1-Year Est. Return

Rydar Equities Weatherford, Texas $194M AUM 23.21% 1-Year Est. Return

DKM Wealth Management's ABCL Position: Q3 2026 in Review

DKM Wealth Management held its AbCellera Biologics (ABCL) position steady in Q3 2026 at 10,000 shares worth $146K. The position accounts for 0.09% of the portfolio, ranked #62.

DKM Wealth Management first reported a position in ABCL in Q4 2024 and has held it in 8 quarters since. 8 funds tracked by Wall St. Rank hold ABCL as of Q3 2026.

DKM Wealth Management held 10,000 shares of AbCellera Biologics worth $146K as of Q3 2026.
DKM Wealth Management left its AbCellera Biologics share count unchanged in Q3 2026.
AbCellera Biologics made up 0.09% of DKM Wealth Management's portfolio in Q3 2026, its #62 holding.
DKM Wealth Management first reported a position in AbCellera Biologics in Q4 2024 and has held it in 8 quarters since.
8 funds tracked by Wall St. Rank held AbCellera Biologics as of Q3 2026.

Based on DKM Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.